A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

SAN DIEGO and CALGARY, AB, July 16, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, summarized its ...

Combining Lynparza (olaparib) and Keytruda (pembrolizumab) showed antitumor activity in multiple cancer types, particularly those with BRCA1/2 mutations In this combination trial patients were matched ...

IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a ...